RIL
WST icon

Rothschild Investment LLC’s West Pharmaceutical WST Stock Holding History

Rothschild Investment LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Sell
90
-630
-88% -$157K ﹤0.01% 1371
2025
Q4 		$198K Buy
720
+20
+3% +$5.47K 0.01% 626
2025
Q3 		$184K Buy
700
+637
+1,011% +$155K 0.01% 639
2025
Q2 		$13.8K Buy
63
+38
+152% +$8.12K ﹤0.01% 1127
2025
Q1 		$5.6K Sell
25
-31
-55% -$8.54K ﹤0.01% 1383
2024
Q4 		$18.3K Buy
56
+6
+12% +$1.89K ﹤0.01% 1019
2024
Q3 		$15K Buy
50
+37
+285% +$11.3K ﹤0.01% 1062
2024
Q2 		$4.28K Sell
13
-9
-41% -$3.18K ﹤0.01% 1230
2024
Q1 		$8.71K Buy
22
+5
+29% +$1.85K ﹤0.01% 1067
2023
Q4 		$5.99K Buy
+17
New +$6.02K ﹤0.01% 1060

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return